UMMS Affiliation

Department of Pediatrics

Date

8-2-2008

Document Type

Article

Medical Subject Headings

Child Development; Child, Preschool; Cystic Fibrosis; Female; Follow-Up Studies; Growth Disorders; Human Growth Hormone; Humans; Infant; Liver Diseases; Male; Treatment Outcome

Disciplines

Endocrinology, Diabetes, and Metabolism | Pediatrics

Abstract

Growth impairment in cystic fibrosis (CF) is worsened by liver disease. Children with CF have serum levels of insulin-like growth factor-I (IGF-I) that are lower than expected for their normal growth hormone (GH) production. In children with CF-related liver disease (CFLD), response to endogenous GH is further reduced. We present our experience with two young children with CFLD given recombinant human GH (rhGH). The first patient was a 5 year-old female with CFLD and poor growth who responded well for 1 1/2 years to rhGH therapy during her initial course and without a significant increase in serum IGF-I, but with a substantial increase in IGF-I concentration when the GH dose was increased. The second patient was a 5 month-old male with advanced liver disease who had transient improved growth and liver function following rhGH. These patients suggest that rhGH is safe and may be effective in children with CFLD.

Rights and Permissions

Citation: J Pediatr Endocrinol Metab. 2008 Aug;21(8):793-7. Link to article on publisher's website

Related Resources

Link to Article in PubMed

 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.